
See how AI has transformed Yiwu shop owners into polyglots in China!
BEIJING,Feb. 14,2025--A news report by China.org.cn on China\'s AI application:  
See how AI has transformed Yiwu shop owners into polyglots in China!
BEIJING,Feb. 14,2025--A news report by China.org.cn on China\'s AI application:  
Triller Joins Forces with Baron Davis' BIG and Influencer Platform REACH for NBA All-Star Weekend
The media powerhouse is taking over NBA All-Star weekend with exclusive content and star-studded experiences,showcasing a new era for digital entertainment
Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA
SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,
OneConnect Integrates DeepSeek into AI Agent Platform
SHANGHAI,Feb. 13,2025-- OneConnect Financial Technology Co.,Ltd ("OneConnect" or the "Company",NYSE: OCFT,HKSE: 6638),a business technology service provider for financial instituti
Hanmi Pharmaceutical Global Business Headquarters Accelerates Expansion into Canadian and US Markets,Strengthening Collaboration with Distribution Partner McKesson
SEOUL,South Korea,Feb. 14,2025-- Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the special meeting of its stockholders
Saudi Ministry of Finance and IMF Prepare to Launch AlUla Conference for Emerging Market Economies
RIYADH,Saudi Arabia,Feb. 14,2025-- The AlUla Conference for Emerging Market Economies,organized jointly by the Saudi Ministry of Finance and the International Monetary Fund (IMF),kicks off next week
TOKYO,Feb. 13,2025-- Polyplastics Co.,Ltd.,a global leader in engineering plastics,has launched PLASTRON (R) LFT (long fiber-reinforced thermoplastic) RA627P,an eco-friendly composite of polypropylene
BANGKOK,Feb. 13,2025-- Webull Securities (Thailand) Co. Ltd. ("Webull Thailand"),the Thai subsidiary of Webull Corporation ("Webull"),a leading global digital investment platform,
XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).